Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Matthew Bigbee"'
Autor:
Conor M. Maxwell, DO, Akash M. Bhat, BS, Samantha J. Falls, DO, Matthew Bigbee, BA, Yue Yin, PhD, Sricharan Chalikonda, MD, David L. Bartlett, MD, Hiran C. Fernando, MBBS, Casey J. Allen, MD
Publikováno v:
JTCVS Open, Vol 17, Iss , Pp 286-294 (2024)
Objective: We used a framework to assess the value implications of thoracic surgeon operative volume within an 8-hospital health system. Methods: Surgical cases for non–small cell lung cancer were assessed from March 2015 to March 2021. High-volume
Externí odkaz:
https://doaj.org/article/9a7ad5cdf74a4ddf99191ac71769cfe3
Autor:
Betty Shindel, Matthew Bigbee, Brittany Colosimo, Christie Hilton, Kevin Weinberger, Stephen Abel, Shaakir Hasan, Steven Gresswell, Thomas B. Julian, Sidney Anderson, Mark Trombetta
Publikováno v:
American journal of clinical oncology. 42(8)
We investigated the downstream workup and costs associated with digital breast tomosynthesis (DBT) compared with 2-dimensional full field digital mammogram (FFDM) when employed as initial follow-up imaging in breast conservation therapy.Between the y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97f8d93aec85e8ad24ff84913137ba3e
https://pubmed.ncbi.nlm.nih.gov/31313678
https://pubmed.ncbi.nlm.nih.gov/31313678
Autor:
Raven Lowery, Emily Graham, Holley Stallings, Lisa Ciafre, Chelsea Strom, Courtney Scheerer, Dana Haines, Patricia Reiser, Matthew Bigbee
Publikováno v:
Journal of Clinical Oncology. 38:192-192
192 Background: The Allegheny Health Network Cancer Institute (AHNCI) Medical Oncology is comprised of 19 infusion clinics located in the western Pennsylvania region. Safety quality assurance data revealed an extravasation rate of 0.12% for vesicant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::687ab5839508e3c7859d8e0d54f5c13f
https://doi.org/10.1200/jco.2020.38.29_suppl.192
https://doi.org/10.1200/jco.2020.38.29_suppl.192
Autor:
Gene Grant Finley, David G. Mayernik, Prachi Kalamkar, Ariel Sandhu, David S. Parda, Matthew Bigbee, Katherine R. Miller
Publikováno v:
Journal of Clinical Oncology. 36:e18563-e18563
e18563Background: Oncology care represents the largest driver of medical cost in the US, projected to exceed $ 173 billion per year by 2020. Previous work has identified physician behavior as a var...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea1c5f608cf19749688039a5f32d2d46
https://doi.org/10.1200/jco.2018.36.15_suppl.e18563
https://doi.org/10.1200/jco.2018.36.15_suppl.e18563
Autor:
Matthew Bigbee, Daniel Jung Lee, David S. Parda, Ariel Sandhu, David G. Mayernik, Gene Grant Finley, Prachi Kalamkar
Publikováno v:
Journal of Clinical Oncology. 36:e18929-e18929
e18929Background: There exists significant variation in lung cancer treatment depending on physician, payer and stage of disease without significant difference in survival or QoL (Quality of Life)....
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d69d18239df7381c05933feb772a81a6
https://doi.org/10.1200/jco.2018.36.15_suppl.e18929
https://doi.org/10.1200/jco.2018.36.15_suppl.e18929
Autor:
Saverio Capuano, JoAnne L. Flynn, Philana Ling Lin, Carolyn Bigbee, Le'Kneitah Smith, Amy J. Myers, Matthew Bigbee, Ion Chiosea, Carl R. Fuhrman, Mark Rodgers, Edwin Klein
Publikováno v:
Infection and Immunity. 77:4631-4642
We previously described that low-dose Mycobacterium tuberculosis infection in cynomolgus macaques results in a spectrum of disease similar to that of human infection: primary disease, latent infection, and reactivation tuberculosis (S. V. Capuano III
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44023ec79c0028c313fb622f58cd5c8e
https://doi.org/10.1128/iai.00592-09
https://doi.org/10.1128/iai.00592-09
Autor:
Edwin Klein, Angela M. Green, Matthew Bigbee, Philana Ling Lin, Carl R. Fuhrman, JoAnne L. Flynn, Tara Rutledge
CD4 T cells are believed to be important in protection against Mycobacterium tuberculosis, but the relative contribution to control of initial or latent infection is not known. Antibody-mediated depletion of CD4 T cells in M. tuberculosis-infected cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0df2f213f874739bf53520bfee1049ff
https://europepmc.org/articles/PMC3505050/
https://europepmc.org/articles/PMC3505050/
Autor:
Jes Dietrich, Mark Rodgers, Esterlina V. Tan, David R. Sherman, Matthew Bigbee, Hannah P. Gideon, Kristi M. Guinn, Catherine Cochran, JoAnne L. Flynn, Edwin Klein, Leslie Milk, Christopher Janssen, Rodolfo M. Abalos, Philana Ling Lin, Carolyn Bigbee, Peter Andersen, Jasmin Burgos
It is estimated that one-third of the world’s population is infected with Mycobacterium tuberculosis. Infection typically remains latent, but it can reactivate to cause clinical disease. The only vaccine, Mycobacterium bovis bacillus Calmette-Gueri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3c110b16f120bbffeafeba8f8673039
https://europepmc.org/articles/PMC3248283/
https://europepmc.org/articles/PMC3248283/